HK1014499A1 - Methods for treating viral infections - Google Patents

Methods for treating viral infections

Info

Publication number
HK1014499A1
HK1014499A1 HK98115815A HK98115815A HK1014499A1 HK 1014499 A1 HK1014499 A1 HK 1014499A1 HK 98115815 A HK98115815 A HK 98115815A HK 98115815 A HK98115815 A HK 98115815A HK 1014499 A1 HK1014499 A1 HK 1014499A1
Authority
HK
Hong Kong
Prior art keywords
image
treating viral
methods
aliphatic
viral infections
Prior art date
Application number
HK98115815A
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of HK1014499A1 publication Critical patent/HK1014499A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98115815A 1992-05-27 1998-12-28 Methods for treating viral infections HK1014499A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/888,976 US5244922A (en) 1990-09-04 1992-05-27 Methods for treating viral infections
PCT/US1993/005002 WO1993024123A1 (fr) 1992-05-27 1993-05-26 Procedes pour le traitement d'infections virales

Publications (1)

Publication Number Publication Date
HK1014499A1 true HK1014499A1 (en) 1999-09-30

Family

ID=25394288

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115815A HK1014499A1 (en) 1992-05-27 1998-12-28 Methods for treating viral infections

Country Status (9)

Country Link
US (1) US5244922A (fr)
EP (1) EP0601164B1 (fr)
AT (1) ATE188871T1 (fr)
AU (1) AU4392793A (fr)
DE (1) DE69327642T2 (fr)
ES (1) ES2142873T3 (fr)
HK (1) HK1014499A1 (fr)
SG (1) SG67344A1 (fr)
WO (1) WO1993024123A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59101214D1 (de) * 1991-07-15 1994-04-21 Artesan Pharma Gmbh Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
AU3474593A (en) * 1992-01-16 1993-08-03 New York University Hypericin treatment of vaccine agents for improved immunogenicity
US5646182A (en) * 1992-06-15 1997-07-08 Burzynski; Stanislaw R. Methods for treating autoimmune diseases
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US5654335A (en) * 1996-02-23 1997-08-05 University Of Iowa Research Foundation Topical use of ethyl ethacrynate for glaucoma treatment
US5565434A (en) * 1996-02-23 1996-10-15 University Of Iowa Research Foundation Hexose and pentose prodrugs of ethacrynic acid
CA2254772C (fr) * 1996-05-14 2004-01-27 Stanislaw R. Burzynski Traitements liposomaux par antineoplastons presentant une activite antineoplasique nettement amelioree
US5932618A (en) * 1996-11-04 1999-08-03 Signal Pharmaceuticals, Inc. Anti-viral agents and methods relating to the use thereof
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
AU8531101A (en) 2000-08-29 2002-03-13 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
EP1511477A4 (fr) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc Inhibiteurs d'histone desacetylase bases sur des composes alpha-ceto-epoxydes
WO2004046104A2 (fr) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Traitement de cellules pulmonaires avec des inhibiteurs d'histone deacetylase
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents
RU2234313C1 (ru) * 2003-06-04 2004-08-20 Кривошеин Юрий Семенович Средство инактивации коронавирусов
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
EP1817020A4 (fr) * 2004-11-08 2012-11-21 Errant Gene Therapeutics Inc Inhibiteurs d'histone deacetylase
US9199959B2 (en) * 2011-10-25 2015-12-01 Shionogi & Co., Ltd. HIV replication inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4427684A (en) * 1982-09-24 1984-01-24 Ores Richard O Treatment and prevention of infection with herpes simplex and related viruses
EP0216555B1 (fr) * 1985-09-11 1992-09-02 Btg International Limited Utilisation de dérivés de la dioxopipéridine pour le traitement de l'anxiété, pour la réduction des niveaux de la sérotonine ou de l'acide 5-hydroxy-indoleacétique chroniquement anormalement élevés dans le cerveau, et pour le traitement des infections bact
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids

Also Published As

Publication number Publication date
EP0601164A1 (fr) 1994-06-15
WO1993024123A1 (fr) 1993-12-09
US5244922A (en) 1993-09-14
ES2142873T3 (es) 2000-05-01
DE69327642T2 (de) 2000-06-08
EP0601164B1 (fr) 2000-01-19
ATE188871T1 (de) 2000-02-15
SG67344A1 (en) 1999-09-21
DE69327642D1 (de) 2000-02-24
EP0601164A4 (fr) 1994-10-26
AU4392793A (en) 1993-12-30

Similar Documents

Publication Publication Date Title
SG67344A1 (en) Methods for treating viral infections
ES2189874T3 (es) Dinucleotidos utiles para el tratamiento de enfermedades pulmonares.
WO1998056761A3 (fr) Derives de benzimidazole
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
EP0786458A3 (fr) Dérivés et analogues d'acide 2-déoxy-2,3-didéhydro-N-acétyle neuraminique et leur utilisation comme agents antiviraux
IT1255222B (it) Fosforotidati di oligonucleotidi ciclici
MY117892A (en) Therapeutic compounds
DE69031340D1 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
KR900701278A (ko) 바이러스 감염 치료용 담즙산
SG81891A1 (en) Compositions and methods for treating autoimmune diseases
US5314689A (en) Acyl-carnitine for the treatment and prevention of viral infections
SG81889A1 (en) Pharmaceutical compositions for use in treating aids
KR880003973A (ko) 약리적 활성 화합물 및 용도
HK1068344A1 (en) Dimeric compounds and their use as anti-viral agents
AU5102296A (en) Use of penciclovir for the treatment of human herpes-virus-8
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.
EP1451181A4 (fr) Composes dimeriques, et leur utilisation comme agents antiviraux
RU98103770A (ru) 2-амино-9-(3-гидроксиметил-4-алкоксикарбонилоксибут-1-ил)пурина и фармацевтическая композиция, содержащая его
GB2267642A (en) Anti-viral agents
RU2001134133A (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
RU97111796A (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
CA2193665A1 (fr) Derives de benzimidazole pour le traitement et la prophylaxie d'infections virales

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100526